Cavernous Sinus Meningiomas: What Does the Literature Tell Us?
Most of our evidence-based data for guiding treatment recommendations for cavernous sinus meningiomas is Class II at best. In this online course Dr. Michael McDermott from the Miami Neuroscience Insitute discusses the individualized staged treatments including microsurgical treatment options and associated risks.
Commercial Supporter
Baptist Health gratefully acknowledges the commercial support provided by Elekta for this activity.
Target Audience
Neurosurgeons, medical physicists, radiation oncologists, neuro-otolaryngologists and nurse practitioners.
Learning Objectives
- Explain the clinical background and management of cavernous sinus meningiomas.
- Describe individualized staged treatments based on each patient’s condition.
- Examine recent evidence-based literature reviews.
Michael W. McDermott, M.D.
Chair, Division of Neurosurgery
Chief Physician Executive
Miami Neuroscience Institute
Irma & Kalman Bass Endowed Chair in Clinical Neuroscience
Rupesh Kotecha, M.D.
Chief of Radiosurgery, Director of CNS Metastasis, Department of Radiation Oncology
Miami Cancer Institute, Baptist Health South Florida
Professor, Department of Radiation Oncology
Herbert Wertheim College of Medicine, Florida International University
Michael McDermott, M.D., conference director and faculty for this educational event, is a consultant with Deinde Medical, Stryker, Insightech and Zap. Dr. McDermott has indicated that the presentations or discussions will not include off-label or unapproved product usage.
Rupesh Kotecha, M.D., conference director and faculty for this educational event, has received an honoraria from Elekta AB, Accuray Inc., Viewray, Novocure, Elsevier and BrainLab. He has received research support from Medtronic, Blue Earth Diagnostics, Novocure, Exelixis, GT Medical Technologies, Astrazeneca and Viewray. He is also a member of the speakers' bureau with Novocure. Dr. Kotecha has indicated that the presentations or discussions will not include off-label or unapproved product usage.
All of the relevant financial relationships listed for this/these individuals has/have been mitigated.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*
*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
Required Hardware/Software
![]() | PC/Mac UsersThis site is supported on the most recent stable releases of the following browsers:
| ||||||
![]() | Mobile UsersThis site is supported on the following mobile devices:
| ||||||
![]() | Technical SupportIf you are experiencing technical difficulties or have received an error message, please send an email to [email protected] and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours. |